Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gilead Sciences
(NQ:
GILD
)
69.61
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gilead Sciences
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
31
32
Next >
Gilead Sciences (GILD) Q2 2023 Earnings Call Transcript
August 04, 2023
GILD earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Will An Earnings Miss Cloud Gilead's Massive Cancer Treatment Growth?
August 03, 2023
Gilead missed earnings expectations Thursday, though reported strong sales growth for cancer drugs.
Via
Investor's Business Daily
US Stock Futures Dip As Apple, Amazon Earnings Loom: Analyst Warns Of 'Perfectly Normal' 5% Pullback This Month
August 03, 2023
Stocks appear to be entrenched in an August swoon and it remains to be seen if big tech earnings provide a boost.
Via
Benzinga
Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points
August 01, 2023
Investors looking to give their portfolio a boost should consider one of these leading biotech names, which are undervalued right now.
Via
InvestorPlace
$1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today
July 31, 2023
Via
Benzinga
Expert Ratings for Gilead Sciences
July 24, 2023
Via
Benzinga
Peering Into Gilead Sciences's Recent Short Interest
July 19, 2023
Via
Benzinga
Here's How Much $1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today
July 18, 2023
Via
Benzinga
3 Stocks Retirees Should Absolutely Love
July 29, 2023
These stocks offer solid income plus more.
Via
The Motley Fool
Trial Setback For Gilead Sciences: Shuts Late-Stage Magrolimab/Azacitidine Combo Study In Type Of Blood Cancer
July 24, 2023
Gilead Sciences Inc (NASDAQ: GILD) decided to discontinue the Phase 3 ENHANCE study in higher-risk myelodysplastic syndromes (MDS) due to futility
Via
Benzinga
Bank of America, Bank of New York Mellon And 2 Other Stocks Insiders Are Selling
July 24, 2023
The Nasdaq 100 closed slightly higher on Friday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Governor DeSantis Says He Would Sue the Drug Company Gilead for Trying to Save Lives
July 23, 2023
DeSantis made it clear that he thinks companies should only maximize profit and be subject to shareholder lawsuits if they do anything other than maximizing profits. So how does this get us to suing...
Via
Talk Markets
2 Growth Stocks That Could Rocket 81% to 233% Higher, According to Wall Street
July 20, 2023
The investment bank analysts who follow these stocks think they could deliver enormous gains in the not-so-distant future.
Via
The Motley Fool
The 7 Most Undervalued Nasdaq Stocks to Buy Now: July 2023
July 19, 2023
The market is soaring, but there is still time to buy these seven undervalued Nasdaq stocks before they head higher.
Via
InvestorPlace
Price Over Earnings Overview: Gilead Sciences
July 17, 2023
Via
Benzinga
This Is What Whales Are Betting On Gilead Sciences
June 30, 2023
Via
Benzinga
Looking Into Gilead Sciences's Recent Short Interest
June 29, 2023
Via
Benzinga
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
July 19, 2023
It helps to offer products everyone needs.
Via
The Motley Fool
SARS-CoV-2 Is Not Done Yet — Could This New Drug In Clinical Trials Be The Safest Option For Treating COVID-19?
July 18, 2023
Read the latest report on NanoViricides here.
Via
Benzinga
Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash
July 17, 2023
These stocks are built to withstand a bear market.
Via
The Motley Fool
FDA Approves Gilead's Remdesivir For COVID-19 Treatment Patients With Severe Renal Impairment
July 14, 2023
The FDA approved Gilead Sciences Inc's (NASDAQ: GILD) supplemental new drug application for using Veklury (remdesivir) in COVID-19 patients with severe renal impairment,
Via
Benzinga
7 Tech Stocks to Watch on July 14
July 12, 2023
Tech stocks are on the rise today ahead of the upcoming Nasdaq 100 rebalancing, the changes for which will be announced this Friday, July 14.
Via
InvestorPlace
Gilead Sciences' Debt Overview
June 29, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
July 12, 2023
Via
Benzinga
Novel Nanomedicine Platform With Pipeline Of Antivirals Goes To Human Trials – What Other Viruses Could This COVID Treatment Target?
July 10, 2023
Read the latest report on NanoViricides here.
Via
Benzinga
Is Johnson & Johnson Stock a Buy Now?
July 09, 2023
Some businesses never go out of style.
Via
The Motley Fool
The 3 Best Biotech Stocks to Buy In July
July 05, 2023
With these companies fueling sales and earnings with medical innovations and breakthroughs, they may be the best biotech stocks to pick up.
Via
InvestorPlace
NanoViricides Inc. (NYSE American: NNVC) Begins Long-Awaited Clinical Trials For Its Anti-Viral Nanomedicine NV-CoV-2, Oral, Amid Continuing Need For COVID Treatment
July 05, 2023
Read the latest report on NanoViricides here.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
June 30, 2023
Via
Benzinga
Amgen Inc. Dividend Stock Analysis
June 30, 2023
The company has paid a cash dividend to shareholders every year since 2011 and has increased its dividend payments for 13 consecutive years.
Via
Talk Markets
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.